Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...

The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...

Medtronic PLC (BVMF:MDTC34) (MDT), a global leader in medical technology, services, and solutions, has reached a new 52-week ...

We recently compiled a list of the 10 Best Halal Dividend Stocks To Invest In. In this article, we are going to take a look ...

If you’re rooting for a sweet mix of growth and dividends, these four US stocks should be on your radar. The post 4 Reputable ...

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

The healthcare IT market is driving digital transformation by enhancing efficiency, addressing workforce shortages, and ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price ...

Barclays analyst Matt Miksic maintained a Buy rating on Intuitive Surgical (ISRG – Research Report) today and set a price target of $684.00.

CEO Robert Ford also plans to expand sales of the company’s Lingo over-the-counter glucose sensors after a limited rollout.

Kuros Biosciences USA entered into a five-year exclusive sales agency agreement with Medtronic spinal division.